CIPLA TIES UP WITH IVAX FOR US MARKET

Cipla has teamed up with generic major Ivax, now Teva, to supply an active pharmaceutical ingredient (API) for a paediatric drug in US market. Following the expiry of the patent on this drug in September last year, Teva bagged the exclusive marketing rights. India Business (http://timesofindia.indiatimes.com/articleshow/1890873.cms)